InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Secures USPTO Patent for PTSD Treatment SPC-15
Silo Pharma (NASDAQ: SILO), a biopharmaceutical company developing novel therapeutics and drug delivery systems, announced that the U.S. Patent and Trademark Office (USPTO) has issued an Issue Notification for its patent application (No. 17/954,864), titled “Pharmacological Prophylactics Against Stress-Induced Affective Disorders in Females.” The patent, which is set to be issued on March 4, 2025, enhances protection for Silo’s lead asset, SPC-15, an intranasal treatment…